Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Impact and Recovery

Dec 2020| TBR1184B| TBRC (Publisher)

Report Highlights

Including: By Application: Chemotherapy Induced Neutropenia; Transplantation; Others
By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Mail Order/ Online Pharmacies

Covering: Coherus Biosciences Inc.; Biocon/Mylan; Sandoz

Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global pegfilgrastim biosimilars market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Description:

Where is the largest and fastest growing market for the pegfilgrastim biosimilars market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global pegfilgrastim biosimilars market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography and segmentation by target antigen and by application.
  • Market Characteristics – The market characteristics section of the report defines and explains the pegfilgrastim biosimilars market. This chapter includes different services covered in the report and basic definitions.
  • Trends And Strategies – This chapter describes the major trends shaping the global pegfilgrastim biosimilars market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • COVID Impact Analysis – This section provides an insight on how the pandemic is impacting the pegfilgrastim biosimilars market.
  • Global Market Size And Growth – This section contains the global historic (2015-2019) and forecast (2023F, 2025F, 2030F) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
  • Regional Analysis – This section contains the historic (2015-2019), forecast (2019-2023F, 2025F, 2030F) market value and growth and market share comparison by region.
  • Market Segmentation – This section contains the market values (2015-2019, 2019-2023F, 2025F, 2030F) and analysis for segment by type in the market.
  • Regional Market Size And Growth – This section contains the region’s market size (2019), historic and forecast (2015-2019, and 2023F, 2025F, 2030F) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
  • Competitive Landscape – This section covers details on the competitive landscape of the global pegfilgrastim biosimilars market, estimated market shares and company profiles of the leading players.
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for pegfilgrastim biosimilars companies in terms of product offerings, geographic expansion, marketing strategies and target groups.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: The global pegfilgrastim biosimilars market is segmented into -

By Application: Chemotherapy Induced Neutropenia; Transplantation; Others
By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Mail Order/ Online Pharmacies

Companies Mentioned: Coherus Biosciences Inc.; Biocon/Mylan; Sandoz

Countries: China, Japan, India, Australia, Indonesia, South Korea, USA, Brazil, UK, Germany, France, Russia.

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 2 : Global Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 3 : Global Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 4 : Global Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 5 : Global Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 6 : Global Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 7 : Global Pegfilgrastim Biosimilars Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 8 : Global Pegfilgrastim Biosimilars Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 9 : Global Pegfilgrastim Biosimilars Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 10 : Global Pegfilgrastim Biosimilars Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 11 : Asia Pacific Estimated Average Expenditure, Pegfilgrastim Biosimilar Market, Cancer Prevalence, 2019
  • Table 12 : Asia-Pacific Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 13 : Asia-Pacific Per Capita Net Disposable Income, 2015-2019, $
  • Table 14 : Asia Pacific Population By Age Group, 2015-2023, Thousands
  • Table 15 : Asia-Pacific Biologics Market Size, 2015-2019, $ Billion
  • Table 16 : Asia-Pacific Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 17 : Asia-Pacific Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 18 : Asia-Pacific Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 19 : Asia-Pacific Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 20 : China Estimated Average Expenditure, Pegfilgrastim Biosimilar Market, Cancer Prevalence, 2019
  • Table 21 : China Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 22 : China Per Capita Net Disposable Income, 2015-2019, $
  • Table 23 : China Population By Age Group, 2015-2023, Thousands
  • Table 24 : China Biologics Market Size, 2015-2019, $ Billion
  • Table 25 : China Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 26 : China Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 27 : China Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 28 : India Estimated Average Expenditure, Pegfilgrastim Biosimilar Market, Cancer Prevalence, 2019
  • Table 29 : India Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 30 : India Per Capita Net Disposable Income, 2015-2019, $
  • Table 31 : India Population By Age Group, 2015-2023, Thousands
  • Table 32 : Asia-Pacific Biologics Market Size, 2015-2019, $ Billion
  • Table 33 : India Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 34 : India Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 35 : India Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 36 : Japan Estimated Average Expenditure, Pegfilgrastim Biosimilar Market, Cancer Prevalence, 2019
  • Table 37 : Japan Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 38 : Japan Per Capita Net Disposable Income, 2015-2019, $
  • Table 39 : Japan Population By Age Group, 2015-2023, Thousands
  • Table 40 : Japan Biologics Market Size, 2015-2019, $ Billion
  • Table 41 : Japan Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 42 : Japan Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 43 : Japan Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 44 : Australia Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 45 : Australia Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 46 : Australia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 47 : Australia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 48 : Indonesia Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 49 : Indonesia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 50 : Indonesia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 51 : South Korea Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 52 : South Korea Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 53 : South Korea Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 54 : South Korea Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 55 : Western Europe Estimated Average Expenditure, Cancer Prevalence, 2019
  • Table 56 : Western Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 57 : Western Europe Per Capita Net Disposable Income, 2015-2019, $
  • Table 58 : Western Europe Population By Age Group, 2015-2023, Thousands
  • Table 59 : Western Europe Biologics Market Size, 2015-2019, $ Billion
  • Table 60 : Western Europe Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 61 : Western Europe Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 62 : Western Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 63 : Western Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 64 : UK Estimated Average Expenditure, Pegfilgrastim Biosimilar Market, Cancer Prevalence, 2019
  • Table 65 : UK Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 66 : UK Per Capita Net Disposable Income, 2015-2019, $
  • Table 67 : UK Population By Age Group, 2015-2023, Thousands
  • Table 68 : UK Biologics Market Size, 2015-2019, $ Billion
  • Table 69 : UK Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 70 : UK Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 71 : UK Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 72 : UK Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 73 : Germany Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 74 : Germany Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 75 : Germany Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 76 : Germany Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 77 : France Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 78 : France Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 79 : France Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 80 : France Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 81 : UK Estimated Average Expenditure, Pegfilgrastim Biosimilar Market, Cancer Prevalence, 2019
  • Table 82 : Eastern Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 83 : Eastern Europe Population By Age Group, 2015-2023, Thousands
  • Table 84 : Eastern Europe Per Capita Net Disposable Income, 2015-2019, $
  • Table 85 : Eastern Europe Biologics Market Size, 2015-2019, $ Billion
  • Table 86 : Eastern Europe Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 87 : Eastern Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 88 : Eastern Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 89 : Russia Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 90 : Russia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 91 : Russia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 92 : North America Estimated Average Expenditure, Pegfilgrastim Biosimilar Market, Cancer Prevalence, 2019
  • Table 93 : North America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 94 : North America Per Capita Net Disposable Income, 2015-2019, $
  • Table 95 : North America Population By Age Group, 2015-2023, Thousands
  • Table 96 : North America Biologics Market Size, 2015-2019, $ Billion
  • Table 97 : North America Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 98 : North America Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 99 : North America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 100 : North America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 101 : North America Estimated Average Expenditure, Pegfilgrastim Biosimilar Market, Cancer Prevalence, 2019
  • Table 102 : USA Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 103 : USA Per Capita Net Disposable Income, 2015-2019, $
  • Table 104 : USA Market, Population By Age Group, 2015-2023, Thousands
  • Table 105 : USA Biologics Market Size, 2015-2019, $ Billion
  • Table 106 : USA Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 107 : USA Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 108 : USA Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 109 : USA Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 110 : South America Estimated Average Expenditure, Pegfilgrastim Biosimilar Market, Cancer Prevalence, 2019
  • Table 111 : South America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 112 : South America Population By Age Group, 2015-2023, Thousands
  • Table 113 : South America Per Capita Net Disposable Income, 2015-2019, $
  • Table 114 : South America Biologics Market Size, 2015-2019, $ Billion
  • Table 115 : South America Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 116 : South America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 117 : South America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 118 : Brazil Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 119 : Brazil Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 120 : Brazil Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 121 : Middle East Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 122 : Middle East Per Capita Net Disposable Income, 2015-2019, $
  • Table 123 : Middle East Population By Age Group, 2015-2023, Thousands
  • Table 124 : Middle East Biologics Market Size, 2015-2019, $ Billion
  • Table 125 : Middle East Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 126 : Middle East Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 127 : Middle East Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 128 : Africa Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 129 : Africa Per Capita Net Disposable Income, 2015-2019, $
  • Table 130 : Africa Population By Age Group, 2015-2023, Thousands
  • Table 131 : Africa Biologics Market Size, 2015-2019, $ Billion
  • Table 132 : Africa Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 133 : Africa Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 134 : Africa Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 135 : Global Pegfilgrastim Biosimilars Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Table 136 : Biocon - Financial Performance, 2015 - 2019, $ Billion
  • Table 137 : Mylan - Financial Performance, 2015 - 2019, $ Billion
  • Table 138 : Sandoz (Novartis) - Financial Performance, 2015 - 2019, $ Billion
  • Table 139 : Global Pegfilgrastim Biosimilars Market Size Gain ($ Million), 2019 - 2023, By Country
  • Table 140 : Global Pegfilgrastim Biosimilars Market Size Gain ($ Million), Segmentation By Application, 2019 - 2023
  • Table 141 : Global Pegfilgrastim Biosimilars Market Size Gain ($ Million), Segmentation By Distribution Channel, 2019 - 2023
  • Table 142 : Pegfilgrastim Biosimilars Market Data Sources
  • Figure 1 : Global Pegfilgrastim Biosimilars Market Segmentation By Application
  • Figure 2 : Global Pegfilgrastim Biosimilars Market Segmentation By Distribution Channel
  • Figure 3 : Global Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 4 : Global Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 5 : Global Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 6 : Global Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 7 : Global Pegfilgrastim Biosimilars Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 8 : Global Pegfilgrastim Biosimilars Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 9 : Asia-Pacific Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 10 : Asia-Pacific Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 11 : Asia-Pacific Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 12 : China Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 13 : China Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 14 : India Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 15 : India Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 16 : Japan Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 17 : Japan Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 18 : Australia Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 19 : Australia Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 20 : Australia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 21 : Indonesia Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 22 : Indonesia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 23 : South Korea Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 24 : South Korea Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 25 : South Korea Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 26 : Western Europe Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 27 : Western Europe Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 28 : Western Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 29 : UK Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 30 : UK Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 31 : UK Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 32 : Germany Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 33 : Germany Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 34 : Germany Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 35 : France Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 36 : France Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 37 : France Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 38 : Eastern Europe Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 39 : Eastern Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 40 : Russia Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 41 : Russia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 42 : North America Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 43 : North America Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 44 : North America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 45 : USA Pegfilgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 46 : USA Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 47 : USA Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 48 : South America Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 49 : South America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 50 : Brazil Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 51 : Brazil Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 52 : Middle East Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 53 : Middle East Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 54 : Africa Pegfilgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 55 : Africa Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 56 : Global Pegfilgrastim Biosimilars Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Figure 57 : Biocon - Financial Performance, 2015 - 2019, $ Billion
  • Figure 58 : Mylan - Financial Performance, 2015 - 2019, $ Billion
  • Figure 59 : Sandoz (Novartis) - Financial Performance, 2015 - 2019, $ Billion

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report